- Home
- ADCT vs PIM Comparison
ADCT vs PIM Comparison
Compare ADCT & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- PIM
- Stock Information
- Founded
- ADCT 2011
- PIM 1988
- Country
- ADCT Switzerland
- PIM United States
- Employees
- ADCT N/A
- PIM N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- PIM Finance Companies
- Sector
- ADCT Health Care
- PIM Finance
- Exchange
- ADCT Nasdaq
- PIM Nasdaq
- Market Cap
- ADCT 143.1M
- PIM 159.3M
- IPO Year
- ADCT 2020
- PIM N/A
- Fundamental
- Price
- ADCT $1.49
- PIM $3.31
- Analyst Decision
- ADCT Strong Buy
- PIM
- Analyst Count
- ADCT 5
- PIM 0
- Target Price
- ADCT $8.50
- PIM N/A
- AVG Volume (30 Days)
- ADCT 344.2K
- PIM 57.5K
- Earning Date
- ADCT 03-27-2025
- PIM 01-01-0001
- Dividend Yield
- ADCT N/A
- PIM 8.28%
- EPS Growth
- ADCT N/A
- PIM N/A
- EPS
- ADCT N/A
- PIM 0.05
- Revenue
- ADCT $70,837,000.00
- PIM N/A
- Revenue This Year
- ADCT $6.81
- PIM N/A
- Revenue Next Year
- ADCT $11.24
- PIM N/A
- P/E Ratio
- ADCT N/A
- PIM $63.80
- Revenue Growth
- ADCT 1.84
- PIM N/A
- 52 Week Low
- ADCT $1.39
- PIM $2.90
- 52 Week High
- ADCT $5.38
- PIM $3.28
- Technical
- Relative Strength Index (RSI)
- ADCT 39.46
- PIM 53.21
- Support Level
- ADCT $1.41
- PIM $3.27
- Resistance Level
- ADCT $1.68
- PIM $3.33
- Average True Range (ATR)
- ADCT 0.12
- PIM 0.04
- MACD
- ADCT -0.03
- PIM 0.00
- Stochastic Oscillator
- ADCT 16.00
- PIM 62.50
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.